Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic ...

Epstein-Barr virus (EBV)-seronegative recipients of EBV-seropositive donor (EBV D+/R−) kidneys have an increased risk for ...

Kidney transplant recipients who’ve never been exposed to the Epstein-Barr virus but receive organs from a donor who has been ...

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children ...

All-cause graft failure risk was higher for recipients of Epstein–Barr virus D-positive/R-negative kidneys. The Epstein–Barr virus D-positive/R-negative group had up to a 10-fold higher ...

Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...

Patients' age ranged from 3 months to 47 years. A specific virus was identified in two patients (one cytomegalovirus [CMV] and one Epstein-Barr virus [EBV]). EGG was pathological in six out of ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Atara ...

Cancer biotech Viracta Therapeutics has closed its doors, laying off all employees and winding down operations.

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...